Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta

MSCs exert therapeutic effects in OI by secreting EVs containing miRNA, and EV therapy has the potential to become a novel cell-free therapy for OI that will overcome some of the current limitations in MSC therapy.